Entering text into the input field will update the search result below

Takeda Pharmaceutical GAAP EPS of ¥150.00, revenue of ¥1.06T

Jul. 27, 2023 6:45 AM ETTakeda Pharmaceutical Company Limited (TAK)By: Deepa Sarvaiya, SA News Editor
  • Takeda Pharmaceutical press release (NYSE:TAK): Q1 GAAP EPS of ¥150.00
  • Revenue of ¥1.06T (+8.9% Y/Y).
  • Revenue Growth of +8.9% at Actual Exchange Rate (AER); +3.7% Growth at Constant Exchange Rate (CER), Driven by Growth & Launch Products (+16.2% at CER)

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About TAK

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Takeda Pharmaceutical Company Limited
Daiichi Sankyo Company, Limited
Bayer Aktiengesellschaft
Astellas Pharma Inc.
Otsuka Holdings Co., Ltd.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.